#172; S6: Same Surgeon, Different Light w/ Dr. Doug Wood

Today, co-hosts Dr. Sara Pereira and Dr. Cherie Erkmen sit down with guest Dr. Bo Yang, who shares his remarkable career path from medical school and early cardiothoracic training at Xiangya University in China, to earning a PhD in pharmacology in the United States, to retraining in surgery at the University of Arizona and Stanford and ultimately joining the University of Michigan as a surgeon-scientist. Along the way, he reflects on the mentors, cultural challenges, and relentless work ethic that carried him through 13 years of retraining. It’s a compelling chat, as Dr. Yang discusses building a basic science lab, while launching a complex aortic practice, developing the Y-incision aortic root enlargement technique, and learning to become a more patient and intentional teacher. offers words of wisdom on the importance of spending time with your family.

In the season two premiere episode of Thinking Thoracic, cohosts Drs. Erin Gillaspie, Hari Keshava, Jeff Yang, and Jane Yanagawa review the latest thoracic surgery research presented at the 2026 STS Annual Meeting in New Orleans.

In the Season 6 premiere episode, live from STS 2026, host Dr. Sara Pereira and guest co-host Dr. Fatima Wilder sit down with Dr. Doug Wood, who shares his extraordinary journey—from growing up on a farm in rural Michigan in a family that valued education, to attending the National Science Foundation Summer Science Program at Purdue University, to becoming a national champion rower at Harvard, and ultimately serving as a division chief, department chair, and leader in lung cancer surgery and advocacy. It’s a fascinating conversation, as he reflects on his career with humility and self-deprecating humor.

Jessica Donington, MD, and Christine Bestvina, MD, join host Erin Gillaspie, MD, to unpack key lung cancer advances from ESMO 2025, including adjuvant ALK inhibition (ALINA, ELEVATE), perioperative immunotherapy (KEYNOTE-671), and the expanding neoadjuvant space in borderline resectable disease.

In this STS blog article, Shubham Gulati, a third-year medical student at the Icahn School of Medicine at Mount Sinai, reflects on a transformative year with his mentor, Dr. Ravi Rajaram, and other accomplished surgeons, who created space for candid discussions about the realities and rewards of becoming a cardiothoracic surgeon.

In this special edition of the Best Science in Lung Cancer series, host Erin Gillaspie, MD, speaks with Paula Ugalde, MD, to examine findings from ELCC, including restaging in the neoadjuvant era, redefining resectability, the use of AI in multidisciplinary precision care, and the current de-escalation debate.

In this special edition of the Best Science in Lung Cancer series, host Erin Gillaspie, MD, sits down with Brendon Stiles, MD, to discuss insights from ASCO, including perioperative immunotherapy, CheckMate 816, and expanding surgical boundaries.

In this special edition of the Best Science in Lung Cancer series, Leah Backhus, MD, joins host Erin Gillaspie, MD, to explore key takeaways from WCLC, including how precision data, surgical restraint, and breakthrough immunotherapy are transforming care.

The latest episode of Thinking Thoracic dives into one of the most challenging diseases in thoracic oncology—malignant pleural mesothelioma. Host Erin Gillaspie, MD, speaks with Joshua Reuss, MD, a thoracic medical oncologist and clinical trials leader, about how immunotherapy, evolving surgical strategies, and global practice patterns are reshaping care for this rare cancer. The episode covers the impact of the Checkmate 743 trial, controversy surrounding the MARS-2 surgical study, promising results from neoadjuvant immunotherapy trials, and the critical need for collaboration and clinical trial enrollment to drive progress. Listen now to explore where mesothelioma research is headed and what it means for patient care.

The occupation we have chosen is the most fulfilling job in the world. Cardiothoracic surgery has been the only career I have pursued as an adult, but I know that even without a meaningful comparison, my bold claim is correct. We have studied and practiced for years to acquire skills so that we can help to cure our patients or at least minimize their suffering. Yet, throughout all of our careers, having a patient succumb to their disease, or our attempt at treating their disease, is as much of a certainty as our own eventual mortality. Read this blog by Dr. Derek Serna-Gallegos on how to face your first patient death as a cardiothoracic surgeon.